Researchmoz added Most up-to-date research on "Global Paclitaxel Market Research Report 2019" to its huge collection of research reports.
Paclitaxel Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the Paclitaxel industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics, Opportunities, Competitive Landscape, Price and Gross Margin, Paclitaxel market Share via Region, New Challenge Feasibility Evaluation, Analysis and Guidelines on New mission Investment.
For more info, Get Free PDF at: https://www.researchmoz.us/enquiry.php?type=S&repid=2159501
Commercially available under the brand name Taxol, paclitaxel is a chemotherapy drug used to treat a number of cancers. Breast cancer, ovarian cancer, and non-small cell lung cancer are some cancers paclitaxel is used for.
In clinical environments, paclitaxel has served to be effective for patients of advanced breast cancer resistant to anthracyclines. This signals increasing uptake of paclitaxel towards treatment of breast cancer.
Paclitaxel is mostly free of side effects, or to the least, side effects are reversible on completion of treatment. This further strengthens uptake of paclitaxel. Displaying such stability, rare among special class of drugs, paclitaxel is one of its kind. This serves to boost the paclitaxel market predicted to rise at a stellar 8.7% CAGR from 2019 to 2025.
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
In the last several years, global market of Paclitaxel developed rapidly, with an average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly 80 M USD; the actual production is about 2600 Kg.
The classification of Paclitaxel includes Natural Paclitaxel API and Semi-Synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 is about 31.3%, and the proportion is decreasing trend from 2012 to 2017.
The global Paclitaxel market is valued at 90 million US$ in 2018 is expected to reach 160 million US$ by the end of 2025, growing at a CAGR of 8.7% during 2019-2025.
This report focuses on Paclitaxel volume and value at global level, regional level and company level. From a global perspective, this report represents overall Paclitaxel market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Segment by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other
Place an Enquiry to Our Industry Expert @ https://www.researchmoz.us/enquiry.php?type=E&repid=2159501
List of Tables and Figures
Figure Picture of Paclitaxel
Table Global Paclitaxel Production (Kg) Growth Rate Comparison by Types (2014-2025)
Figure Global Paclitaxel Production Market Share by Types in 2018
Figure Natural Paclitaxel API Product Picture
Table Natural Paclitaxel API Major Manufacturers
Figure Semi-synthetic Paclitaxel API Product Picture
Table Semi-synthetic Paclitaxel API Major Manufacturers
Table Global Paclitaxel Consumption (Kg) Comparison by Applications (2014-2025)
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us ;
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow us on Blogger at : https://marketreportandanalysis.blogspot.com
Paclitaxel Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the Paclitaxel industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics, Opportunities, Competitive Landscape, Price and Gross Margin, Paclitaxel market Share via Region, New Challenge Feasibility Evaluation, Analysis and Guidelines on New mission Investment.
For more info, Get Free PDF at: https://www.researchmoz.us/enquiry.php?type=S&repid=2159501
Commercially available under the brand name Taxol, paclitaxel is a chemotherapy drug used to treat a number of cancers. Breast cancer, ovarian cancer, and non-small cell lung cancer are some cancers paclitaxel is used for.
In clinical environments, paclitaxel has served to be effective for patients of advanced breast cancer resistant to anthracyclines. This signals increasing uptake of paclitaxel towards treatment of breast cancer.
Paclitaxel is mostly free of side effects, or to the least, side effects are reversible on completion of treatment. This further strengthens uptake of paclitaxel. Displaying such stability, rare among special class of drugs, paclitaxel is one of its kind. This serves to boost the paclitaxel market predicted to rise at a stellar 8.7% CAGR from 2019 to 2025.
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
In the last several years, global market of Paclitaxel developed rapidly, with an average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly 80 M USD; the actual production is about 2600 Kg.
The classification of Paclitaxel includes Natural Paclitaxel API and Semi-Synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 is about 31.3%, and the proportion is decreasing trend from 2012 to 2017.
The global Paclitaxel market is valued at 90 million US$ in 2018 is expected to reach 160 million US$ by the end of 2025, growing at a CAGR of 8.7% during 2019-2025.
This report focuses on Paclitaxel volume and value at global level, regional level and company level. From a global perspective, this report represents overall Paclitaxel market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Segment by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other
Place an Enquiry to Our Industry Expert @ https://www.researchmoz.us/enquiry.php?type=E&repid=2159501
List of Tables and Figures
Figure Picture of Paclitaxel
Table Global Paclitaxel Production (Kg) Growth Rate Comparison by Types (2014-2025)
Figure Global Paclitaxel Production Market Share by Types in 2018
Figure Natural Paclitaxel API Product Picture
Table Natural Paclitaxel API Major Manufacturers
Figure Semi-synthetic Paclitaxel API Product Picture
Table Semi-synthetic Paclitaxel API Major Manufacturers
Table Global Paclitaxel Consumption (Kg) Comparison by Applications (2014-2025)
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us ;
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow us on Blogger at : https://marketreportandanalysis.blogspot.com
No comments:
Post a Comment